Drobni, Z. D., Mayrhofer, T., Hoffmann, U., & Neilan, T. G. (2021). Response to Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque". Circulation, 143(25), e1033. https://doi.org/10.1161/CIRCULATIONAHA.121.054169
Chicago Style (17th ed.) CitationDrobni, Zsofia D., Thomas Mayrhofer, Udo Hoffmann, and Tomas G. Neilan. "Response to Sarayani Et Al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque"." Circulation 143, no. 25 (2021): e1033. https://doi.org/10.1161/CIRCULATIONAHA.121.054169.
MLA (9th ed.) CitationDrobni, Zsofia D., et al. "Response to Sarayani Et Al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque"." Circulation, vol. 143, no. 25, 2021, p. e1033, https://doi.org/10.1161/CIRCULATIONAHA.121.054169.